41 unknown. 41 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 41 | Unknown 41 |
| Phase 2 | 4 | Unknown 4 |
Follow Pulmonary Disease, Chronic Obstructive: new trials by email Literature Review of Pulmonary Disease, Chronic Obstructive trials Research Report on Pulmonary Disease, Chronic Obstructive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Citrulline Supplementation in COPD Patients With Malnutrition L-citrulline - Chronic Obstructive Pulmonary Disease Severe, Malnutrition | Phase 3 | Unknown | University Hospital, Grenoble | 60 | 2024-01-25 | 2024-01-19 |
| Clopidogrel for the Prevention of Exacerbations in Severe COPD Clopidogrel Bisulfate 75Mg Tab - COPD, COPD Exacerbation Acute | Phase 3 | Unknown | Lady Reading Hospital, Pakistan | 162 | 2023-10-01 | 2023-10-03 |
| Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD | Phase 3 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 74 | 2023-09-28 | 2023-10-03 |
| N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD N-acetylcysteine, Placebo - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Queen Mary Hospital, Hong Kong | 80 | 2023-09-18 | 2023-11-18 |
| Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD | Phase 3 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 74 | 2023-08-25 | 2023-09-05 |
| The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation Furosemide, Normal saline - Chronic Obstructive Pulmonary Disease Exacerbation, COPD Exacerbation | Phase 3 | Unknown | American University of Beirut Medical Center | 200 | 2023-03-01 | 2023-03-15 |
| Inhaled Amikacin in Preventing AECOPD aerosol inhaled Amikacin Sulfate Injection, conventional therapy - COPD, COPD Exacerbation | Phase 3 | Unknown | Shanghai Zhongshan Hospital | 136 | 2022-03-01 | 2022-02-23 |
| The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) Conventional rehabilition treatment(e.g leaflet) educated by hospital, Digital treatment based on Respiratory Rehabilitation Software - Respiratory System Disease, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Lifesemantics Corp. | 100 | 2022-01-13 | 2022-03-29 |
| Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD Acetazolamide, Placebo - Chronic Obstructive Pulmonary Disease, Altitude Sickness | Phase 3 | Unknown | University of Zurich | 100 | 2021-06-01 | 2023-03-03 |
| Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide, Placebo - Right Heart Function, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | University of Zurich | 100 | 2021-05-01 | 2022-11-02 |
| A Trial of Procalcitonin in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease procalcitonin-guided antibiotic therapy, guideline-guided antibiotic therapy - Procalcitonin, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Capital Medical University | 500 | 2021-02-01 | 2020-12-24 |
| Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure Yiqi Huoxue Huatan granule, Placebo Yiqi Huoxue Huatan granule - Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure | Phase 3 | Unknown | Peking University People's Hospital | 372 | 2019-10-08 | 2020-01-07 |
| Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD Bufei Yishen granule, Placebo Bufei Yishen granule, Tiotropium Bromide Powder for Inhalation - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 348 | 2019-06-01 | 2019-06-06 |
| Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD Bufei Jianpi granule, Placebo Bufei Jianpi granule - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 612 | 2019-06-01 | 2019-06-06 |
| High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease salbutamol - Chronic Obstructive Pulmonary Disease, High-flow Nasal Cannula | Phase 3 | Unknown | Poitiers University Hospital | 25 | 2019-01-11 | 2019-02-12 |
| Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD Salbutamol (Ventolin®), Tiotropium Bromide (Spiriva®), Salmeterol / fluticasone (Seretide®) - Pulmonary Disease, Chronic Obstructive | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 240 | 2018-06-20 | 2018-11-19 |
| Effects of Traditional Chinese Medicine on AECOPD Patients TCM and conventional drug, TCM placebo and conventional drug - Pulmonary Disease, Chronic Obstructive, Acute Exacerbation | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 378 | 2018-03-01 | 2018-02-09 |
| Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease Acupuncture, Conventional drug, Acupuncture plus conventional drug - Pulmonary Disease, Chronic Obstructive | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 150 | 2017-05-01 | 2017-05-30 |
| Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients HCP1202, HGP1011, HCP0910 - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Hanmi Pharmaceutical Company Limited | 252 | 2016-10-01 | 2016-10-21 |
| Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD Spiromax Budesonide/formoterol, Diskus Fluticasone/salmeterol - COPD | Phase 3 | Unknown | University Medical Center Groningen | 201 | 2015-05-01 | 2019-07-10 |
Showing 20 of 41. Sign in to see all of them.
Emphysema (4) · Dyspnea (3) · Altitude Sickness (2) · Heart Failure (2) · Hypertension, Pulmonary (2) · Lung Neoplasms (2) · Respiratory Tract Diseases (2) · Asthma (1) · Diabetes Mellitus (1) · Hypertension (1) · Hypoxia (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Lymphoma, Follicular (1)
Chronic Disease (41) · Disease Attributes (41) · Pathologic Processes (41) · Pathological Conditions, Signs and Symptoms (41) · Lung Diseases (40) · Lung Diseases, Obstructive (40) · Respiratory Tract Diseases (39) · Respiration Disorders (6) · Signs and Symptoms (5) · Cardiovascular Diseases (4) · Signs and Symptoms, Respiratory (4) · Neoplasms (3) · Nutritional and Metabolic Diseases (3) · Vascular Diseases (3) · Heart Diseases (2)
Albuterol (6) · Salmeterol Xinafoate (5) · Fluticasone-Salmeterol Drug Combination (4) · Fluticasone (3) · Inhalation (3) · Acetazolamide (2) · Formoterol Fumarate (2) · Ipratropium (2) · Standard of Care (2) · Tiotropium Bromide (2) · Acetylcysteine (1) · Acupuncture Therapy (1) · Analgesics, Opioid (1) · Azithromycin (1) · Budesonide (1)
Henan University of Traditional Chinese Medicine (8) · Neutec Ar-Ge San ve Tic A.Ş (2) · University of Zurich (2) · American University of Beirut Medical Center (1) · Associazione Riabilitatori Insufficienza Respiratoria (1) · Bridgeport Hospital (1) · Broncus Technologies (1) · C. T. Lamont Primary Care Research Centre (1) · CHU de Reims (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Capital Medical University (1) · Edmond Pharma (1) · Groningen Research Institute for Asthma and COPD (1) · Hanmi Pharmaceutical Company Limited (1) · Heidelberg University (1)
China (7) · United Kingdom (6) · United States (4) · Canada (3) · France (3) · Italy (3) · Netherlands (3) · Germany (2) · Kyrgyzstan (2) · Spain (2) · Turkey (Türkiye) (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1)
Jiansheng Li, Professor (2) · Suyun Li, Doctor (2) · Andrew Wilson, MD, MRCP (UK) (1) · Carmine D. Vizza, MD (1) · Constantine Manthous, MD (1) · Dennis Jensen, Ph. D. (1) · Felix JF Herth, MD (1) · Gerhard W. Sybrecht, Prof. Dr. med. (1) · Hisham Bou Fakhreddine, MD (1) · HyoungKyu Yoon, M.D., Ph.D. (1) · Jacques Lemelin, MD (1) · Jadwiga A Wedzicha (1) · Jadwiga A Wedzicha, MD (1) · Jiansheng Li, Doctor (1)
PMID 18385168, PMID 18710905, PMID 18723437, PMID 20008582, PMID 20090057, PMID 20154234, PMID 21214899, PMID 21599896, PMID 21861914, PMID 21907863, PMID 22459779, PMID 22893340, PMID 23506695, PMID 24885672, PMID 25358424, PMID 25849109, PMID 26179246, PMID 26685116, PMID 26757466, PMID 27044249, PMID 28578708, PMID 29025888, PMID 29269583, PMID 29743071, PMID 30464447, PMID 31842969, PMID 34353802, PMID 34505172, PMID 37955027, PMID 39108325, PMID 39956529, PMID 40394700, PMID 40609812, PMID 40854157, PMID 41295088